Join the Varubi group to help and get support from people like you.
Varubi News
FDA Medwatch Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter - Anaphylaxis and Other Serious Hypersensitivity Reactions
ISSUE: Anaphylaxis, anaphylactic shock and other serious hypersensitivity reactions have been reported in the postmarketing setting, some requiring hospitalization. These reactions have occurred...
Tesaro Announces U.S. FDA Approval of Varubi IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy
WALTHAM, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) – Tesaro, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Varubi (rolapitant) for Chemotherapy-Induced Nausea and Vomiting
September 2, 2015 – The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Nausea / Vomiting - Chemotherapy Induced